Reuters logo
BRIEF-Molecular Partners regains rights to multi-DARPin drug candidate
October 6, 2016 / 5:30 AM / a year ago

BRIEF-Molecular Partners regains rights to multi-DARPin drug candidate

Oct 6 (Reuters) - Molecular Partners AG :

* Molecular Partners regains rights to multi-DARPin drug candidate targeting IL-13 & IL-17 for pulmonary indications from Janssen

* Termination of collaboration with Janssen in immunology does not impact Molecular Partners’ strategy Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below